Reviewed,
UniProtKB/Swiss-Prot P14420 (PA21B_VIPAE)
Last modified
June 16, 2009.
Version 79.
History...
Clusters with 100%,
90%,
50% identity |
Documents (2) |
Third-party data |
Customize display | text xml rdf/xml gff fasta |
Names and origin
| Protein names | Recommended name: Phospholipase A2 EC=3.1.1.4 Alternative name(s): Phosphatidylcholine 2-acylhydrolase Vipoxin non-toxic component Vipoxin B chain |
| Organism | Vipera ammodytes meridionalis (Eastern sand viper) |
| Taxonomic identifier | 73841 [NCBI] |
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Lepidosauria › Squamata › Scleroglossa › Serpentes › Colubroidea › Viperidae › Viperinae › Vipera |
Protein attributes
| Sequence length | 122 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is not processed. |
| Protein existence | Evidence at protein level. |
General annotation (Comments)
| Function | PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. The vipoxin complex show postsynaptic neurotoxicity, while the isolated phospholipase A2 is a presynaptic neurotoxin. |
| Catalytic activity | Phosphatidylcholine + H2O = 1-acylglycerophosphocholine + a carboxylate. |
| Cofactor | Binds 1 calcium ion per subunit By similarity. |
| Subunit structure | The main toxin of this snake venom is vipoxin, a complex of a toxic basic protein (B chain) having phospholipase A2 activity and a nontoxic acidic protein (A chain) functioning as its inhibitor. Without the inhibitor, the basic protein becomes unstable and within 12-14 days loses its enzymatic activity. |
| Subcellular location | |
| Tissue specificity | Expressed by the venom gland. |
| Miscellaneous | The supposed calcium binding region close to Asp-48 of the basic phospholipase A2 is blocked by the side chain of Lys-60 of its inhibitor. |
| Sequence similarities | Belongs to the phospholipase A2 family. Group II subfamily. |
Ontologies
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 122 | 122 | Phospholipase A2 | PRO_0000161712 | ||||||||||||||||||||||||||||
Sites | ||||||||||||||||||||||||||||||||
| Active site | 47 | 1 | By similarity | |||||||||||||||||||||||||||||
| Active site | 89 | 1 | By similarity | |||||||||||||||||||||||||||||
| Metal binding | 27 | 1 | Calcium; via carbonyl oxygen By similarity | |||||||||||||||||||||||||||||
| Metal binding | 29 | 1 | Calcium; via carbonyl oxygen By similarity | |||||||||||||||||||||||||||||
| Metal binding | 31 | 1 | Calcium; via carbonyl oxygen By similarity | |||||||||||||||||||||||||||||
| Metal binding | 48 | 1 | Calcium By similarity | |||||||||||||||||||||||||||||
Amino acid modifications | ||||||||||||||||||||||||||||||||
| Disulfide bond | 26 ↔ 115 | |||||||||||||||||||||||||||||||
| Disulfide bond | 28 ↔ 44 | |||||||||||||||||||||||||||||||
| Disulfide bond | 43 ↔ 95 | |||||||||||||||||||||||||||||||
| Disulfide bond | 49 ↔ 122 | |||||||||||||||||||||||||||||||
| Disulfide bond | 50 ↔ 88 | |||||||||||||||||||||||||||||||
| Disulfide bond | 57 ↔ 81 | |||||||||||||||||||||||||||||||
| Disulfide bond | 75 ↔ 86 | |||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||
| Helix | 2 – 13 | 12 | ||||||||||||||||||||||||||||||
| Helix | 17 – 21 | 5 | ||||||||||||||||||||||||||||||
| Beta strand | 22 – 24 | 3 | ||||||||||||||||||||||||||||||
| Turn | 25 – 27 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 28 – 30 | 3 | ||||||||||||||||||||||||||||||
| Helix | 39 – 52 | 14 | ||||||||||||||||||||||||||||||
| Turn | 59 – 61 | 3 | ||||||||||||||||||||||||||||||
| Beta strand | 66 – 69 | 4 | ||||||||||||||||||||||||||||||
| Beta strand | 72 – 75 | 4 | ||||||||||||||||||||||||||||||
| Helix | 80 – 98 | 19 | ||||||||||||||||||||||||||||||
| Helix | 100 – 102 | 3 | ||||||||||||||||||||||||||||||
| Helix | 105 – 107 | 3 | ||||||||||||||||||||||||||||||
| Helix | 112 – 114 | 3 | ||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| [1] | "Sequence homology between phospholipase and its inhibitor in snake venom. The primary structure of phospholipase A2 of vipoxin from the venom of the Bulgarian viper (Vipera ammodytes ammodytes, Serpentes)." Mancheva I., Kleinschmidt T., Aleksiev B., Braunitzer G. Biol. Chem. Hoppe-Seyler 368:343-352(1987) [PubMed: 3606821] [Abstract] Cited for: PROTEIN SEQUENCE. Strain: Bulgarian. Tissue: Venom. |
| [2] | "Crystals of phospholipase A2 inhibitor. The non-toxic component of vipoxin from the venom of Bulgarian viper (Vipera ammodytes)." Devedjiev Y., Atanasov B., Mancheva I., Aleksiev B. J. Mol. Biol. 229:1147-1149(1993) [PubMed: 8445639] [Abstract] Cited for: CRYSTALLIZATION. Tissue: Venom. |
| [3] | "Crystallization and preliminary X-ray analysis of vipoxin, a complex between a toxic phospholipase A2 and its natural polypeptide inhibitor." Betzel C., Visanji M., Wilson K.S., Genov N., Mancheva I., Aleksiev B., Singh T.P. J. Mol. Biol. 231:498-500(1993) [PubMed: 8510159] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS). Tissue: Venom. |
| [4] | "Crystal structure of vipoxin at 2.0 A: an example of regulation of a toxic function generated by molecular evolution." Perbandt M., Wilson J.C., Eschenburg S., Mancheva I., Aleksiev B., Genov N., Willingmann P., Weber W., Singh T.P., Betzel C. FEBS Lett. 412:573-577(1997) [PubMed: 9276469] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2 ANGSTROMS). |
| [5] | "Structure of the neurotoxic complex vipoxin at 1.4 A resolution." Banumathi S., Rajashankar K.R., Notzel C., Aleksiev B., Singh T.P., Genov N., Betzel C. Acta Crystallogr. D 57:1552-1559(2001) [PubMed: 11679719] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (1.4 ANGSTROMS). |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PIR | A29290. | ||||||||||||||||||||||||
3D structure databases | |||||||||||||||||||||||||
| |||||||||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||||||||
| HOVERGEN | P14420. | ||||||||||||||||||||||||
Enzyme and pathway databases | |||||||||||||||||||||||||
| BRENDA | 3.1.1.4. 294522. | ||||||||||||||||||||||||
Family and domain databases | |||||||||||||||||||||||||
| InterPro | IPR016090. Phospholipase_A2. IPR013090. Phospholipase_A2_AS. IPR001211. Phospholipase_A2_euk. [Graphical view] | ||||||||||||||||||||||||
| Gene3D | G3DSA:1.20.90.10. Phospholipase_A2. 1 hit. | ||||||||||||||||||||||||
| PANTHER | PTHR11716. Phospholipase_A2. 1 hit. | ||||||||||||||||||||||||
| Pfam | PF00068. Phospholip_A2_1. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PRINTS | PR00389. PHPHLIPASEA2. | ||||||||||||||||||||||||
| ProDom | PD000303. PhospholipaseA2. 1 hit. [Graphical view] [Entries sharing at least one domain] | ||||||||||||||||||||||||
| SMART | SM00085. PA2c. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| PROSITE | PS00119. PA2_ASP. 1 hit. PS00118. PA2_HIS. 1 hit. [Graphical view] | ||||||||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||||||||
Entry information
| Entry name | PA21B_VIPAE | ||||||||
| Accession | Primary (citable) accession number: P14420 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
Relevant documents
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with


